These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10844708)

  • 1. Analysis of longitudinal data in an Alzheimer's disease clinical trial.
    Thomas RG; Berg JD; Sano M; Thal L
    Stat Med; 2000 Jun 15-30; 19(11-12):1433-40. PubMed ID: 10844708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
    Sano M; Ernesto C; Thomas RG; Klauber MR; Schafer K; Grundman M; Woodbury P; Growdon J; Cotman CW; Pfeiffer E; Schneider LS; Thal LJ
    N Engl J Med; 1997 Apr; 336(17):1216-22. PubMed ID: 9110909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selegiline and vitamin E in Alzheimer's disease.
    Adelman A
    J Fam Pract; 1997 Aug; 45(2):98-100. PubMed ID: 9267360
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Alzheimer's disease -- searching for a breakthrough, settling for less.
    Drachman DA; Leber P
    N Engl J Med; 1997 Apr; 336(17):1245-7. PubMed ID: 9110915
    [No Abstract]   [Full Text] [Related]  

  • 5. Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study.
    Sano M; Ernesto C; Klauber MR; Schafer K; Woodbury P; Thomas R; Grundman M; Growdon J; Thal LJ
    Alzheimer Dis Assoc Disord; 1996; 10(3):132-40. PubMed ID: 8876776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E for Alzheimer's disease and mild cognitive impairment.
    Isaac MG; Quinn R; Tabet N
    Cochrane Database Syst Rev; 2008 Jul; (3):CD002854. PubMed ID: 18646084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN
    J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-tocopherol and Alzheimer's disease.
    Kilander L; Ohrvall M
    N Engl J Med; 1997 Aug; 337(8):572-3. PubMed ID: 9265107
    [No Abstract]   [Full Text] [Related]  

  • 9. Selegiline for Alzheimer's disease.
    Birks J; Flicker L
    Cochrane Database Syst Rev; 2000; (2):CD000442. PubMed ID: 10796544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis in Alzheimer's disease].
    Kitamura S
    Nihon Rinsho; 2004 Jan; 62 Suppl():81-5. PubMed ID: 15011325
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug treatment for Alzheimer's disease.
    Tom T; Cummings JL
    West J Med; 1998 Apr; 168(4):264. PubMed ID: 9584667
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-tocopherol and Alzheimer's disease.
    Pincus MM
    N Engl J Med; 1997 Aug; 337(8):572; author reply 573. PubMed ID: 9265106
    [No Abstract]   [Full Text] [Related]  

  • 13. Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?
    Ames D; Ritchie C
    Int Psychogeriatr; 2007 Feb; 19(1):1-8. PubMed ID: 17310512
    [No Abstract]   [Full Text] [Related]  

  • 14. Study suggests antioxidants slow decline in Alzheimer's disease.
    Am J Health Syst Pharm; 1997 Jul; 54(13):1478, 1481. PubMed ID: 9217935
    [No Abstract]   [Full Text] [Related]  

  • 15. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
    Filip V; Kolibás E
    J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.
    Mulnard RA; Cotman CW; Kawas C; van Dyck CH; Sano M; Doody R; Koss E; Pfeiffer E; Jin S; Gamst A; Grundman M; Thomas R; Thal LJ
    JAMA; 2000 Feb; 283(8):1007-15. PubMed ID: 10697060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy.
    Wallin AK; Gustafson L; Sjögren M; Wattmo C; Minthon L
    Dement Geriatr Cogn Disord; 2004; 18(2):197-206. PubMed ID: 15211076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease management.
    Cummings JL
    J Clin Psychiatry; 1998; 59 Suppl 13():4-5. PubMed ID: 9771824
    [No Abstract]   [Full Text] [Related]  

  • 19. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
    Fillit H; Cummings J
    Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.